These are the first two CME articles on hair transplantation to ever be published in the leading peer reviewed journal in our field. I am proud to be one of its authors.
During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.
More promising news in the treatment of alopecia areata. More clinical trials are needed to ensure safety and efficacy but very promising.
This analysis demonstrates that there is no increased risk of cancer when using spironolactone.
For some highly motivated patients, a combination of two therapies can be effective in helping hair loss.
The New England Journal of Medicine published an interesting article on vaccine effectiveness and the need for boosters.
The attached article from the FDA outlines the medical risks associated with JAK(Janus kinase) inhibitors for the treatment of alopecia totalis and universalis.
This report gives patients a new and safe therapeutic option to treat chronic inflammatory scalp disorders like folliculitis decalvans.
Interesting article regarding study showing no surgery scars in mice.
Interesting study giving us more information regarding the possible cause of alopecia areata.
The study published in the Lancet in January 2021 regarding long term clinical effects of recovered COVID-19 patients confirms what we have seen in our office over the past several months - increased rates of hair loss.
A recent study shows an association between finasteride use and psychological adverse events.
We have seen a vast increase in hair loss patients who have suffered from COVID.
This article shows more evidience that combination therapy is synergistic in treating hair loss. This study compares low-level light therapy alone and in combination with 5% minoxidil.
Informative review of nonsurgical hair loss treatment options in which Dr. Marc Avram was quoted. Very informative and would recommend to read it if you are concerned about hair loss and are wondering what your options are, before considering surgery.
Recent studies have shown a positive role for PRP in hair loss for men and women.
This observational study shows a high incidence of androgenetic alopecia among COVID-19 patients.
Hair loss telemedicine appointments are available monday thru friday.
Due to COVID-19 restrictions and for the health and well-being of our patients and staff, we are offering telemedicine appointments from the safety of your home.
Low Level Light Therapy continues to be an effective treatment alone or as an adjunct to other medical therapies.
Combination therapy is important for the success of treatment of male and female hair loss.
A large number of patients suffer from scarring alopecia and are hopeful that PRP can help.
Interesting study showing positive impact of PRP on hair loss for men and women.
Clinical trials currently underway to find significant developments for the treatment of Alopecia Areata
Important article addressing post-finasteride syndrome. More data is needed to clarify how common and who it is most likely to affect.
Increasing reports of JAK inhibitors being used as a potential topical treatment option for treating alopecia areata.
What to expect after a hair transplant procedure.
Recent reports showing PRP being used successfully in treatment of scarring alopecias and alopecia areata
Does having a thicker head of hair help protect against skin cancer?
Another paper has been published that demonstrates the synergy between minoxidil and low level light therapy ( LLLT ).
This paper shows a significant development of LLLT for scarring hair loss conditions, such as lichen planopilaris.
New published paper showing the effectiveness of topical minoxidil and LLLT in combination
Low-Level Laser Therapy
Hair Regimentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Pro
Fascinating case reports that may give researchers further insights into the cause and treatment of Alopecia Areata.
